Hexo May Be Expanding, But Its Stock Continues To Drop
Investing.com | Jul 20, 2021 08:25
Shares of Hexo (NYSE:HEXO) (TSX:HEXO) continued to slide last week, even after the company released positive financial results for the privately held company, Redecan Pharm, which the cannabis grower announced it was buying earlier this year.
In May, Hexo announced it would buy Redecan, a Canadian-based cannabis producer, for C$925 million (US$725 million). The move was touted as another indication of the resurging consolidation in the cannabis sector in an effort to gain market share. It is also estimated the deal would make Hexo the third largest cannabis operator in Canada.
According to the figures released last week, Redecan posted C$73.6 million (US$57.8 million) in revenue in 2020. In the first quarter of 2021, the company generated C$24.7 million (US$19.4 million) in revenue, a jump of 146% compared with the same period the previous year. Net earnings for 2020 came in at $22.6 million.
But shares of Hexo, which opened at $4.94 on July 14, the day the figures were released, steadily marched downward for the rest of the week, closing yesterday in New York at $4.20, losing another 4% on the day. Shares of Hexo are up almost 51% in the last year, but have lost more than 40% since the beginning of 2021.
US Cannabis Legislation Underwhelms Markets/h2
The long awaited US legislation that will pave the way to federal legalization of marijuana did very little to bolster cannabis stocks after it was finally unveiled last week.
A draft of the Cannabis Administration and Opportunity Act was introduced in the US Senate, but the stock market barely took notice.
The legislation is viewed as a comprehensive push to end federal prohibition of marijuana and allow regulated cannabis companies access to financial services.
At its base, the law would no longer list cannabis as a controlled substance and regulate the industry.
Now, the bill will be open to receive comments from the public until September.
But despite its much vaunted anticipation and being heralded as a game-changer for the cannabis sector, the main sponsor of the legislation, Senator Chuck Schumer, admitted last week that he doubts whether he has enough votes to get the bill through the Senate. But that did not dampen enthusiasm for the bill from industry executives on both sides of the Canada-US border.
Global Cannabis Index Regaining Momentum/h2
The Global Cannabis Stock Index is showing a little momentum of late, gaining 14% so far in 2021.
In the early years of the legal cannabis industry, the index saw huge upswings, gaining almost 90% in 2016 and topping 90% in 2017. The next two years it registered heavy losses, dropping almost 55% in 2018 and just over 34% in 2019.
Last year, it reversed course, gaining a modest 5.2% in 2020. Now, the gains are accelerating.
The index includes 44 cannabis stocks.
Get The App
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.